Patients on hemodialysis who consumed one month Standardized Aronia Melanocrpa extract

Renal Disease

Dialysis; Complications

Anemia

During 30 days all patients take every day 30ml of Alixir 400 protect

Alixir 400 Protect

Faculty of Medical Science

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis: Focus on Oxidative Stress and Inflammation

Superoxide anion radical, Hydrogen peroxide, Nitrites Units nmol/ml

Superoxide dismutase, Catalase Units U/g Hb x 1000

Reduced glutathione Unit nmol/l RBC x 1000

The parameters of inflammation CRP Unit mg/l

The parameters of inflammation TNF alpha Unit pg/ml

The parameters of inflammation white blood cells Unit x 1000000000 cells/l

Isidora Milosavljevic

Assistant professor

University of Kragujevac

Pharmanova d.o.o., Obrenovac, Serbia

The right side will be treated with radiofrequency

The left side will not receive treatment.

Adiposity

Abdominal Obesity

The volunteers will receive radiofrequency (TECAR-BTL® device, with epidermal temperature above 40ºC) in the right infraumbilical abdominal region, with an application time of 10 minutes (2 minutes per applicator area) and the left region will be used as control. A single session will be held. After approximately 30 days of this application the material for histological analysis will be collected during the surgical act, at which point the skin and the subcutaneous tissue of the infraumbilical region are discarded by the surgeon.

Radiofrequency

Adriana mendonça

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue in the Abdominal Region

The percentage of collagen, elastic fibers and the analysis of the amount and volume of the adipose vacuole will be marked by the Image J® program and registered in a Microsoft Excel worksheet- For the variables percentage of collagen, elastic fibers, number of fibroblasts and number of adipocytes will be performed the normality test with Shapiro Wilk. The paired t test will be used when data are normal and Wilcoxon when not normal. The differences observed will be considered significant when the probability of rejection of the null hypothesis is less than 0.05.

Andreia Noites

Professor/Investigator

Escola Superior de Tecnologia da Saúde do Porto

Universidade Federal do Triangulo Mineiro

The assessor will not know, when analyzing the samples, to which group they belong.

Root Canal Treatment with hand instruments:Root canal treatment was done with instrumentation using manual K files.

Root canal treatment with Protaper instruments:Root canal treatment was done using ProTaper rotary files S1, S2, F1, and F2.

Root canal treatment with hybrid instrumentation:Root canal treatment was carried out using ProTaper and Hyflex CM files.

Apical Periodontitis

Root canal treatment was performed with K files.

Root Canal Treatment with hand instruments

Root canals were enlarged with S1 S2 F1F2 F2 Protaper instruments

Root canal treatment with Protaper instruments

Root canal were enlarged with combination of a combination of ProTaper Universal instruments to shape the coronal and middle thirds and Hyflex CM to prepare the apical third

Root canal treatment with hybrid instrumentation

Effect of Different Instrumentation Technique on Endodontic Outcome

Effect of Different Instrumentation Technique on Outcome of Primary Non Surgical Endodontic Treatment

Periapical radiolucency was graded as Periapical Index (PAI) and scores less than 3 were grded as success

Absence of pain tenderness sinus or swelling was graded as clinical success

Pain intensity before and after treatment was recorded using 0-100 mm VAS scale

Postgraduate Institute of Dental Sciences Rohtak

Men and women 18 years + with a histological diagnosis of IBD (ulcerative colitis or Crohn's disease) who are undergoing a colonoscopy prior to starting a non-corticosteroid immunosuppressive agent

Venous blood, anal swabs, vaginal swabs, high resolution anoscopy (HRA), anal biopsy samples

Men and women 18 years + with a histological diagnosis of IBD (ulcerative colitis or Crohn's disease) who are undergoing a colonoscopy prior to starting a non-corticosteroid immunosuppressive agent
Venous blood samples, anal swab samples, vaginal swab samples, high resolution anoscopy (HRA), anal biopsy samples: Before and at least 6 months after starting a new non-steroid immunosuppressive agent for IBD treatment, eligible participants who are attending for routine colonoscopy will have:
Anal swab samples (and vaginal swab samples for female participants) for human papillomavirus PCR typing (6, 11, 16, 18, 31, 33, 45, 52, 58)
High-resolution anoscopy and biopsy of all visible high-grade dysplastic lesions based on validated colposcopic criteria
Anal cytology testing

Inflammatory Bowel Disease, Immunosuppressive Agent

Sex: Female, Male

Region of Enrollment

Number of participants with Crohn's Disease

Number of participants with Ulcerative Colitis

Number of participants with Indeterminate Colitis

Anal (and vaginal for female participants) HPV PCR typing (6, 11, 16, 18, 31, 33, 45, 52, 58) using the SYBR-Green-based real-time PCR assay with a reverse line blot assay for genotyping of HPV in the positive samples and Taqman probe-based real-time PCR assays for quantification of individual HPV subtypes

Number of Participants With Anal HPV of Any Type, Single Type, and Multiple Types

Percent of Participants With HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and/or 58

High-resolution anoscopy with anal cytology testing

Number of Participants With Abnormal Anal Cytology (ASC-US, ASC-H, LSIL, HSIL, Cancer)

High resolution anoscopy and biopsy of all visible high-grade dysplastic lesions based on validated colposcopic criteria

Number of Participants Who Had One or More Anal Biopsies

Number of Participants With High-grade Anal Dysplasia Lesions

Overall Study

Ross Cranston

Inflammatory Bowel Disease (IBD)

Ulcerative Colitis (UC)

Crohn's Disease (CD)

Anal Human Papillomavirus

Before and at least 6 months after starting a new non-steroid immunosuppressive agent for IBD treatment, eligible participants who are attending for routine colonoscopy will have:
Anal swab samples (and vaginal swab samples for female participants) for human papillomavirus PCR typing (6, 11, 16, 18, 31, 33, 45, 52, 58)
High-resolution anoscopy and biopsy of all visible high-grade dysplastic lesions based on validated colposcopic criteria
Anal cytology testing

acetic acid/nekrose

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue

Effect of Different Instrumentation Technique on Endodontic Outcome

Anal Human Papillomavirus in Inflammatory Bowel Disease Study

Den mest komplette database med medicinske urter understøttet af videnskab